Monthly Archives: November 2012

Targeted Medical Pharma Signs Agreement to Assign Certain Accounts Receivables to Cambridge Medical Funding Group

Los Angeles, November 27, 2012 — Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and sells prescription medical foods to physicians and pharmacies for the treatment of chronic disease, today reported the completion of an agreement under which certain accounts receivables will be assigned to New Jersey-based Cambridge Medical Funding Group, LLC (CMFG). Under the terms of the agreement, medical providers who purchase products from Targeted Medical Pharma will have the option to assign certain accounts receivables from California Continue reading →

Targeted Medical Pharma Presents at the California Association of Healthcare Facilities’ Annual Convention

Los Angeles, November 14, 2012 — David Silver, M.D., executive vice president of scientific and medical affairs at Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), discussed the utilization of prescription only medical foods in a skilled nursing setting at this year’s California Association of Health Facilities’ 62nd annual convention, held  in Palm Springs, Calif., on November 12. The presentation, “Safer and More Effective Pharmacologic Alternatives,” focused on the safety and efficacy of prescription medical foods for the long term management of pain, cognitive and Continue reading →

Theramine® Featured on Lifetime Television Network’s “The Balancing Act”

Los Angeles, Nov. 13, 2012 – Lifetime Network’s “The Balancing Act,” recently featured the prescription-only medical food Theramine, an effective medication for reducing inflammation and pain associated with chronic pain syndromes. During the segment, William Shell, M.D., Chief Executive Officer and Chief Scientific Officer of Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), discussed the benefits of Theramine for the dietary management of syndromes such as fibromyalgia and back pain. Theramine is a prescription-only medical food regulated by the FDA and specially formulated to meet the increased Continue reading →

Targeted Medical Pharma to Present at Upcoming Investor Conferences

Los Angeles, November 5, 2012 – Targeted Medical Pharma, Inc. (OTCQB: TRGM) (OTCBB: TRGM), a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, today announced that members of its executive team are scheduled to present and conduct one-on-one meetings at the following investor conferences: Wednesday, November 7, 2012 14th Annual SoCal Bio Conference & Exhibition Omni Hotel – 251 South Olive Street, Los Angeles, CA 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time) Thursday, November 29, Continue reading →